Premna latifolia Leaves Against Cariogenic Bacteria
This 2015 laboratory study examined antibacterial activity in Premna latifolia leaf extracts against bacteria recovered from dental samples. Researchers prepared extracts with water, methanol, ethanol, chloroform and hexane, then selected the methanolic extract following preliminary phytochemical screening. Samples from 25 dental patients yielded 32 bacterial isolates belonging to five Streptococcus species. The selected extract inhibited all five species in a dose-dependent manner. These results concern laboratory bacterial inhibition, not demonstrated prevention or treatment of dental caries.
What the study did and found
Researchers extracted Premna latifolia leaves using five solvents: water, methanol, ethanol, chloroform and hexane. Preliminary phytochemical screening detected the greatest range of constituents in the methanolic extract, which was selected for antibacterial testing.
Cariogenic samples from 25 dental patients produced 32 bacterial isolates representing five Streptococcus species. The methanolic extract inhibited all five tested species, with greater inhibition reported at higher extract concentrations. Species identities, individual isolate counts and exact inhibition measurements were not provided in the reported findings.
Why it is cited
The study links plant-extract screening with microbiological testing of bacteria originating from dental samples. Its main contribution is a reported dose-dependent antibacterial response to a crude methanolic leaf extract.
The results offer a starting point for investigating plant-derived compounds, but do not identify the substances responsible for inhibition or establish that an oral-care product would be effective.
The findings are preliminary and laboratory-based. They demonstrate an inhibitory response in cultured bacteria, not an improvement in dental health among patients. The individual bacterial species, quantitative potency measurements and minimum inhibitory concentrations were not established in the information reported here. Further work would need to identify active constituents, standardize extraction, assess reproducibility and safety, and evaluate any potential clinical application. No therapeutic dose or human treatment benefit was demonstrated. |
The topic today
Plant-derived antibacterial compounds remain a subject of laboratory research, including possible applications related to oral microorganisms. For Premna latifolia, the 2015 results support additional chemical and microbiological study rather than clinical claims.
Clear identification of bacterial strains, measured potency and testing under conditions relevant to the oral environment would help determine the significance of the initial observations.